REVIEW ARTICLE
Year : 2022 | Volume
: 18 | Issue : 2 | Page : 323--328
Recent advances in nonsurgical treatment of pulmonary ground-glass nodules
Yongmei Kong1, Hui Xu1, Yahan Huang1, Xinyuan Lv2, Xin Ye4
1 Shandong First Medical University & Shandong Academy of Medical Sciences., Taian; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, Shandong, China
2 Kweichow Moutai Hospital, Zunyi, Guizhou, China
Correspondence Address:
Xin Ye
Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, No. 16766, Jingshi Road, Jinan, Shandong Province 250014
China
Since the 1990s, low-dose computed tomography technology has been used in lung cancer screening. With the increase of computed tomography screening, the detection rate of ground-glass nodules (GGN) has increased dramatically. At present, the main treatment strategy for GGN is surgical resection. However, for patients with poor cardiopulmonary functions, a history of lung resection, multiple pulmonary nodules, or the age of >75 years, surgical resection is very difficult and not medically encouraged. This article reviews the applications and outcomes evaluation of nonsurgical treatments, such as chemotherapy, radiotherapy, moleculartargeted drug therapy, immunity therapy, and image-guided thermal ablation in patients with GGN.
How to cite this article:
Kong Y, Xu H, Huang Y, Lv X, Ye X. Recent advances in nonsurgical treatment of pulmonary ground-glass nodules.J Can Res Ther 2022;18:323-328
|
How to cite this URL:
Kong Y, Xu H, Huang Y, Lv X, Ye X. Recent advances in nonsurgical treatment of pulmonary ground-glass nodules. J Can Res Ther [serial online] 2022 [cited 2022 Jun 25 ];18:323-328
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2022;volume=18;issue=2;spage=323;epage=328;aulast=Kong;type=0 |
|
